PharmaCom BioVet, Inc. Introduces Novel Cancer Treatments in Partnership With IsoTherapeutics Group

RALEIGH, NC--(Marketwire - October 15, 2008) - PharmaCom BioVet, Inc. (PINKSHEETS: PHMB) is pleased to announce they have entered into a collaborative agreement with IsoTherapeutics Group (ITG) to co-develop and introduce novel therapeutic treatments for companion animals.
MORE ON THIS TOPIC